Author(s):
Muhammad Reza Arifianto, Wihasto Suryaningtyas, Muhammad Arifin Parenrengi
Email(s):
muhammad.arifin@fk.unair.ac.id
DOI:
10.52711/0974-360X.2023.00900 
Address:
Muhammad Reza Arifianto1,2, Wihasto Suryaningtyas1,2, Muhammad Arifin Parenrengi1,2*
1Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
2Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
*Corresponding Author
Published In:
Volume - 16,
Issue - 12,
Year - 2023
ABSTRACT:
Children with coagulopathy had a greater mortality rate after moderate to severe traumatic brain injury (TBI). The purpose of the current study was to examine the most recent relevant literature in relation to the therapy of TIC in pediatric isolated severe TBI patients. A 5 years old boy presented to emergency department with decrease of consciousness after hit by a motorcycle. He was referred from the district hospital without proper stabilization within 3 hours after the injury. From the blood examination, hemoglobin level was 8.1 g/dl, base deficit -9.9mEq/L with PTT and aPTT no coagulation suggesting coagulopathy. Emergency non-contrast head computed tomography was performed and showed anterior skull base fracture with discontinuity in left squamous suture suggesting a diastases fracture with an air hypodensity lesion in left frontal area suggesting a pneumocephalus. There was also a hyperdense lesion with crescent shape in frontal and interhemispheric region suggesting subdural hematoma. Delayed operation for almost 6 hours was advocated due to transfusion of whole blood and fresh frozen plasma to correct coagulopathy. The operation was successful, the patient was survived but upon 2 years follow up, the patient still wasn’t able to perform normal daily activity. Localized injury at the brain manifesting in systemic coagulopathy requires special care. Several steps need to be evaluated before surgery but it should not delay the attempt of controlling the source of coagulopathy by it means lesion in the brain. Our case demonstrates the important of recognizing and managing coagulopathy in severe traumatic brain injury.
Cite this article:
Muhammad Reza Arifianto, Wihasto Suryaningtyas, Muhammad Arifin Parenrengi. Severe Traumatic Brain Injury Induced Coagulopathy in Pediatric: An Important Lesson with Literature Review. Research Journal of Pharmacy and Technology. 2023; 16(12):5569-5. doi: 10.52711/0974-360X.2023.00900
Cite(Electronic):
Muhammad Reza Arifianto, Wihasto Suryaningtyas, Muhammad Arifin Parenrengi. Severe Traumatic Brain Injury Induced Coagulopathy in Pediatric: An Important Lesson with Literature Review. Research Journal of Pharmacy and Technology. 2023; 16(12):5569-5. doi: 10.52711/0974-360X.2023.00900 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-12-1
REFERENCES:
1. Hon KL, Huang S, Poon WS, Cheung HM, Ip P, Zee B. Mortality And Morbidity of Severe Traumatic Brain Injuries; A Pediatric Intensive Care Unit Experience Over 15 Years. Bull Emerg Trauma. 2019; 7: 256–262.doi.org/10.29252/beat-070308
2. Derakhshanfar H, Pourbakhtyaran E, Rahimi S, Sayyah S, Soltantooyeh Z, Karbasian F. Pediatric clinical guidelines for traumatic brain injuries Clinical guidelines for traumatic brain injuries in children and boys. European Journal of Translational Myology. 2020; 30:8614.
3. Kannan N, Ramaiah R, Vavilala MS. Pediatric Neurotrauma. Int J Crit Illn Inj Sci. 2014; 4: 131–137.doi.org/10.4103/2229-5151.134152
4. Chhabra G, Sharma S, Subramanian A, Agrawal D, Sinha S, Mukhopadhyay AK. Coagulopathy as prognostic marker in acute traumatic brain injury. J Emerg Trauma Shock. 2013; 6:180–185.doi.org/10.4103/0974-2700.115332
5. Harhangi BS, Kompanje EJO, Leebeek FWG, Maas AIR. Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien). 2008; 150:165–175.doi.org/10.1007/s00701-007-1475-8
6. Kushimoto S, Yamamoto Y, Shibata Y, Sato H, Koido Y. Implications of Excessive Fibrinolysis and α2-Plasmin Inhibitor Deficiency in Patients with Severe Head Injury. Neurosurgery. 2001; 49:1084.
7. Davis JW, Davis IC, Bennink LD, et al. Placement of Intracranial Pressure Monitors: Are “Normal” Coagulation Parameters Necessary? Journal of Trauma and Acute Care Surgery. 2004; 57:1173.doi.org/10.1097/01.TA.0000151257.79108.FB
8. Talving P, Benfield R, Hadjizacharia P, Inaba K, Chan LS, Demetriades D. Coagulopathy in severe traumatic brain injury: a prospective study. J Trauma. 2009; 66:55–61. doi.org/10.1097/TA.0b013e318190c3c0
9. Talving P, Lustenberger T, Lam L, et al. Coagulopathy after isolated severe traumatic brain injury in children. J Trauma. 2011; 71: 1205–1210.doi.org/10.1097/TA.0b013e31820d151d
10. Choudhary A, Sharma R, Kumar A, Kinja K, Berwal R, Sharma S. Prevalence of 25-Hydroxyvitamin D Deficiency and its severity correlation with Acute Traumatic brain Injury in Indian Patients: A Perspective Observation Study. Research Journal of Pharmacy and Technology. 2021; 14: 3874–3878.doi.org/10.52711/0974-360X.2021.00672
11. Sunarto OI, Bajamal AH, Abdurachman. Outcome of Brain Injury Patients After Decompressive Craniectomy in Tertiary Referral Hospital in East Java Indonesia. Research Journal of Pharmacy and Technology. 2019; 12:6057–6061.doi.org/10.5958/0974-360X.2019.01051.5
12. Pascual J, Prieto R. Surgical Management of Severe Closed Head Injury in Adults. Schmidek and Sweet Operative Neurosurgical Techniques: Indications, Methods, and Results: Sixth Edition 2012; 2:1513–1549.doi.org/10.1016/B978-1-4160-6839-6.10133-9
13. Duque P, Mora L, Levy J, Schöchl H. Pathophysiological Response to Trauma-Induced Coagulopathy: A Comprehensive Review. Anesthesia and Analgesia. 2019; 130: 1. doi.org/10.1213/ANE.0000000000004478
14. R AP, Vincent J, Gopinath S. Benign Intracranial Hypertension Secondary to Intranasal Corticosteroid Administration. Research Journal of Pharmacy and Technology. 2022; 15: 5548–5550.doi.org/10.52711/0974-360X.2022.00936
15. Khoshimov NN, Raimova GM, Nasirov KE, Mamatova ZA, Mamadaliyeva NI, Тuraev AS. The effect of Sulphated cellulose on System of Haemostasis. Research Journal of Pharmacy and Technology. 2021; 14: 3283–3289. doi.org/10.52711/0974-360X.2021.00571
16. Kochanek PM, Tasker RC, Carney N, et al. Guidelines for the Management of Pediatric Severe Traumatic Brain Injury, Third Edition: Update of the Brain Trauma Foundation Guidelines, Executive Summary. Neurosurgery. 2019; 84: 1169–1178. doi.org/10.1093/neuros/nyz051
17. Por CS, Rajagopal MS, Akowuah GA, Chinnappan S, Abdullah NH. Treatment of Primary Dysmenorrhea Affecting Menstruating Women Using Herbs: A Review. The Natural Products Journal. 2022; 12:11–23.doi.org/10.2174/2210315512666220329151557
18. Simmons JW, Powell MF. Acute traumatic coagulopathy: pathophysiology and resuscitation. BJA: British Journal of Anaesthesia. 2016; 117: 31–43.doi.org/10.1093/bja/aew328
19. Gautam V, Gaurav A. NOS Inhibitors: Structure, Biological Activity and Mechanism of Action. Current Enzyme Inhibition. 12:16–29.
20. Kornblith LZ, Moore HB, Cohen MJ. Trauma‐induced coagulopathy: The past, present, and future. Journal of Thrombosis and Haemostasis. 2019; 17: 852–862. doi.org/10.1111/jth.14450
21. Moore EE, Moore HB, Kornblith LZ, et al. Trauma-induced coagulopathy. Nat Rev Dis Primers. 2021; 7:1–23. doi.org/10.1038/s41572-021-00264-3
22. van Gent JAN, van Essen TA, Bos MHA, Cannegieter SC, van Dijck JTJM, Peul WC. Coagulopathy after hemorrhagic traumatic brain injury, an observational study of the incidence and prognosis. Acta Neurochir (Wien). 2020; 162:329–336.doi.org/10.1007/s00701-019-04111-z
23. Abdullah MI, Ahmad A, Yusoff NAM, et al. Effect of Calorie on Cognitive Function among Traumatic Brain Injury (TBI) Patients: A Pilot Study. Research Journal of Pharmacy and Technology. 2020; 13:4545–4549.doi.org/10.5958/0974-360X.2020.00801.X
24. Saikhedkar R, Verma E. Role of Medications in the Treatment of Alveolar Osteitis: A Review. Research Journal of Pharmacy and Technology. 2015; 8:1445–1448. doi.org/10.5958/0974-360X.2015.00259.0
25. Galgano M, Toshkezi G, Qiu X, Russell T, Chin L, Zhao L-R. Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors. Cell Transplant. 2017; 26: 1118–1130. doi.org/10.1177/0963689717714102
26. Genzen JR, Tormey CA, Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Pathology consultation on reporting of critical values. Am J Clin Pathol. 2011; 135:505–513. doi.org/10.1309/AJCP9IZT7BMBCJRS
27. Rani P, Panda NB, Hazarika A, Ahluwalia J, Chhabra R. Trauma-Induced Coagulopathy: Incidence and Outcome in Patients with Isolated Traumatic Brain Injury in a Level I Trauma Care Center in India. Asian J Neurosurg. 2019; 14: 1175–1180..doi.org/10.4103/ajns.AJNS_126_19
28. Burje S, Rungta S, Shukla A. Detection and Classification of MRI Brain Images For Head/Brain Injury Using Soft Computing Techniques. Research Journal of Pharmacy and Technology. 2017; 10: 715–720. doi.org/10.5958/0974-360X.2017.00134.2
29. Venugopalan A, Karunanithi K, Tp S, et al. Prevalence of Non-Communicable Disease in HIV Infected patients coming to Emergency Medicine and Critical Care Department in A Tertiary Care Centre in South India. Research Journal of Pharmacy and Technology. 2023; 16: 1743–1748. doi.org/10.52711/0974-360X.2023.00287
30. Carrick MM, Tyroch AH, Youens CA, Handley T. Subsequent development of thrombocytopenia and coagulopathy in moderate and severe head injury: support for serial laboratory examination. J Trauma. 2005; 58: 725–729 doi.org/10.1097/01.ta.0000159249.68363.78
31. S S, Murthykumar K, Soundarajan S, Naveed N. Garlic, its Role in Oral Health-A Review. Research Journal of Pharmacy and Technology. 2014; 7:727–729.
32. Verma S, Khanna R, Godkhindi V, S AV, V S, Zeeshan SM. Study of Coagulation parameters in HIV patients and its relation to CD4 counts and ART status. Research Journal of Pharmacy and Technology. 2023; 16: 489–494. doi.org/10.52711/0974-360X.2023.00083
33. Phan C-W, Wang J-K, Cheah S-C, Naidu M, David P, Sabaratnam V. A review on the nucleic acid constituents in mushrooms: nucleobases, nucleosides and nucleotides. Crit Rev Biotechnol. 2018; 38: 762–777.doi.org/10.1080/07388551.2017.1399102
34. Cucher D, Harmon L, Myer B, et al. Critical traumatic brain injury is associated with worse coagulopathy. J Trauma Acute Care Surg. 2021; 91:331–335.doi.org/10.1097/TA.0000000000003253
35. You C, Lu S, Fu Y, Xu F. Relationship between admission coagulopathy and prognosis in children with traumatic brain injury: a retrospective study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2021; 29. doi.org/10.1186/s13049-021-00884-4
36. Wong FH, Palanirajan VK, Ng ESC, Tan CK, Tan ESS, Amini F. Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines. Pharmaceuticals. 2022; 15:1075.doi.org/10.3390/ph15091075
37. Carnevale JA, Segar DJ, Powers AY, et al. Blossoming contusions: identifying factors contributing to the expansion of traumatic intracerebral hemorrhage. Journal of Neurosurgery. 2018; 129: 1305–1316.doi.org/10.3171/2017.7.JNS17988
38. Zhang J, Zhang F, Dong J. Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury. Blood. 2018; 131: 2001–2006. doi.org/10.1182/blood-2017-11-784108
39. Maegele M. Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options. Transfusion. 2013; 53: 28S-37S. doi.org/10.1111/trf.12033
40. Por CS, R M, Akowuah GA, Chinnappan S, Abdullah NH. Polyherbal Formulation for Primary Dysmenorrhea: A Review. Research Journal of Pharmacy and Technology. 2022; 15: 1891–1900. doi.org/10.52711/0974-360X.2022.00316
41. Tian Y, Salsbery B, Wang M, et al. Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury. Blood. 2015; 125:2151–2159.doi.org/10.1182/blood-2014-09-598805
42. Zhou Y, Cai W, Zhao Z, et al. Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice. Blood. 2018; 131:563–572. doi.org/10.1182/blood-2017-08-801738
43. Hayakawa M, Gando S, Ono Y, Wada T, Yanagida Y, Sawamura A. Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study. Semin Thromb Hemost 2015; 41:35–42.doi.org/10.1055/s-0034-1398379
44. Martin G, Shah D, Elson N, et al. Relationship of Coagulopathy and Platelet Dysfunction to Transfusion Needs After Traumatic Brain Injury. Neurocrit Care. 2018; 28:330–337.doi.org/10.1007/s12028-017-0485-5
45. Wohlauer MV, Moore EE, Thomas S, et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg. 2012; 214:739–746. doi.org/10.1016/j.jamcollsurg.2012.01.050
46. Kutcher ME, Redick BJ, McCreery RC, et al. Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg. 2012; 73:13–19. doi.org/10.1097/TA.0b013e318256deab
47. Lustenberger T, Talving P, Kobayashi L, et al. Time course of coagulopathy in isolated severe traumatic brain injury. Injury. 2010; 41:924–928.doi.org/10.1016/j.injury.2010.04.019
48. Nakae R, Takayama Y, Kuwamoto K, Naoe Y, Sato H, Yokota H. Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury. Journal of Neurotrauma. 2016; 33:688–695.doi.org/10.1089/neu.2015.4039
49. Fleck RA, Vijaya Mohan Rao L, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thrombosis Research. 1990; 57:765–781.doi.org/10.1016/0049-3848(90)90034-A
50. Eddleston M, Torre JC de la, Oldstone MB, Loskutoff DJ, Edgington TS, Mackman N. Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. J Clin Invest. 1993; 92:349–358.doi.org/10.1172/JCI116573
51. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion. 2009; 49: 2652–2660. doi.org/10.1111/j.1537-2995.2009.02335.x
52. Hayakawa M, Gando S, Ono Y, et al. Noble-Collip Drum Trauma Induces Disseminated Intravascular Coagulation But Not Acute Coagulopathy of Trauma-Shock. Shock. 2015; 43:261–267.doi.org/10.1097/SHK.0000000000000281
53. Hiippala S. Replacement of massive blood loss. Vox Sang. 1998; 74 Suppl 2:399–407.doi.org/10.1111/j.1423-0410.1998.tb05449.x
54. Rizoli SB, Scarpelini S, Callum J, et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma. 2011; 71:S427-434.doi.org/10.1097/TA.0b013e318232e5ab
55. Floccard B, Rugeri L, Faure A, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury. 2012; 43:26–32.doi.org/10.1016/j.injury.2010.11.003
56. Medved L, Nieuwenhuizen W. Molecular mechanisms of initiation of fibrinolysis by fibrin. Thromb Haemost. 2003; 89:409–419.
57. Filler AG, Haynes J, Jordan SE, et al. Sciatica of nondisc origin and piriformis syndrome: diagnosis by magnetic resonance neurography and interventional magnetic resonance imaging with outcome study of resulting treatment. Journal of Neurosurgery: Spine. 2005; 2:99–115.doi.org/10.3171/spi.2005.2.2.0099
58. Brommer EJP. The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards. Thrombosis Research. 1984; 34: 109–115.doi.org/10.1016/0049-3848(84)90067-7
59. Emeis JJ. Regulation of the Acute Release of Tissue-type Plasminogen Activator from the Endothelium by Coagulation Activation Products. Annals of the New York Academy of Sciences. 1992; 667: 249–258. doi.org/10.1111/j.1749-6632.1992.tb51622.x
60. Karri J, Cardenas JC, Matijevic N, et al. Early Fibrinolysis Associated with Hemorrhagic Progression Following Traumatic Brain Injury. Shock. 2017; 48: 644. doi.org/10.1097/SHK.0000000000000912
61. Yanagida Y, Gando S, Sawamura A, et al. Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: Comparison with acute coagulopathy of trauma-shock. Surgery. 2013; 154: 48–57. doi.org/10.1016/j.surg.2013.02.004
62. Huber D, Cramer EM, Kaufmann JE, et al. Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo. Blood. 2002; 99: 3637–3645. doi.org/10.1182/blood.V99.10.3637
63. Lowenstein CJ, Morrell CN, Yamakuchi M. Regulation of Weibel–Palade Body Exocytosis. Trends in Cardiovascular Medicine. 2005; 15: 302–308.doi.org/10.1016/j.tcm.2005.09.005
64. Kooistra T, Schrauwen Y, Arts J, Emeis JJ. Regulation of endothelial cell t-PA synthesis and release. Int J Hematol. 1994; 59: 233–255.
65. Zhang J, Jiang R, Liu L, Watkins T, Zhang F, Dong J. Traumatic Brain Injury-Associated Coagulopathy. Journal of Neurotrauma. 2012; 29:2597–2605.doi.org/10.1089/neu.2012.2348
66. Albert V, Arulselvi S, Agrawal D, Pati HP, Pandey RM. Early posttraumatic changes in coagulation and fibrinolysis systems in isolated severe traumatic brain injury patients and its influence on immediate outcome. Hematol Oncol Stem Cell Ther. 2019; 12: 32–43. doi.org/10.1016/j.hemonc.2018.09.005
67. Garton HJL. Coagulation Studies in Preoperative Neurosurgery Patients. Anticoagulation and Hemostasis in Neurosurgery. 2016: 285–296. doi.org/10.1007/978-3-319-27327-3_21